Archived Facts

DRUG DEVELOPMENT HALTED: Indianapolis drugmaker Eli Lilly and Co. said Tuesday it stopped developing the potential Alzheimer’s disease treatment semagacestat when late-stage studies showed it did not slow the disease, and patients taking it fared worse than those on a placebo.

See the article here:
Summary Box: Lilly halts Alzheimer’s drug

Popular Posts:

Related Posts:

Leave a Reply